BRIEF—Pandion Therapeutics raises $58 million and appoints new chief executive

Retrieved on: 2018-01-17 23:56:15

Tags for this article:

Health

Biotechnology

Click the tags to see associated articles and topics

BRIEF—Pandion Therapeutics raises $58 million and appoints new chief executive. View article details on hiswai:

Excerpt

<div>East Coast, USA-based Pandion Therapeutics has raised $58 million in a series A funding round, co-led by <b>Polaris Partners</b>, Versant Ventures and Roche Venture Fund. The firm says the money will be used to advance its initial drug programs for autoimmune and inflammatory diseases toward the clinic ...</div>

Article found on:

View Original Article